Xeophin initial coin offering (ICO)

Developing a suite of Class Leading Immunotherapeutics



Xeophin has devised a funding pathway to develop the XeRA-1 Therapeutic for Rheumatoid Arthritis, however this offering represents much more than stake in a promising pharmaceutical. Xeophins’ unique approach to Biotech funding can change the paradigm of how medicine is financed. Xeophin is tokenizing 50% of the future royalties generated by XeRA-1, allowing its’ token holders to fund, and benefit from its’ success. Our mission is to take our core technologies and drive them through our six step process. The outcome being a transaction-ready and IP protected technology portfolio, tokenized. From then on, Xeophin will undertake commercialization activities to achieve a significant royalty deal, delivering value to our XeRA-1 Token holders. Being backed by a physical asset, the XeRA-1 Arthritis Therapeutic, the XERA1 token can increase in value as milestones are hit on the road to commercialization. Once live, token holders will yield cash royalty payments, commensurate to XeRA-1s’ earnings.

0
1 1 expert ratings
2.3
0
0
0
View rating distribution
Starts in 1 second ago
2019-08-17 - 2019-08-17
Token
XRA
Type
ERC20
Bonus
Available
Price in ICO
1 XRA = 1 USD
Platform
Accepting
Raised
0
preICO start
Aug 20, 2018
preICO end
Feb 22, 2019
More on ICO
Report

About Xeophin ICO

Xeophin Pt y Ltd is a Melbourne, Australia based, Biotech Company with a focus on imunomodulating technologies, and is commit ted to the research, development and commercialisation of new and novel medical treatment s, in a number of high grow th therapeutic areas such as inflammation.

Our mission and vision are simple: “Take our core technologies and drive them through our six step process. The outcome being a transaction ready and IP protected technolog y por t folio. From this Xeophin will under take commercialisation activities to achieve a significant royalt y deal, delivering value to our XeR A-1 Token holders”.

In his position as Chief Executive Of ficer, Troy Neilson brings significant, relevant and recent Biotech experience along with extensive management skills. Travis Molloy as Executive Chairman brings 15 years experience in the development stage Biotech space and governance. Caroline Cook as Non-Executive Director brings to the organisation a wealth of project management, outsourcing and leadership experience.

Xeophin is currently a private and unlisted Australian company. Formal policies and best practice from Corporate Governance to Financial Management have been implemented from inception. Xeophin will reorganise and transition it self into the USA , this entit y is referred to NewCo at this stage. It is the NewCo entit y that will seek SEC compliance and undertake the formal ICO*.

Xeophin reviews

PlumBot
ICO Analyzer Bot
Rated on Sep 23, 2018
0
0
0
100%

Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.

Ratings and ICO analyzer results are being updated (re-calculated) every few hours.

Xeophin ICO price

Price in ICO

1 XRA = 1 USD

Xeophin (XRA) crypto

Xeophin coin

Xeophin token
XRA
Xeophin type
ERC20
Xeophin platform

Xeophin (XRA) value

Tokens for sale
345450000

Xeophin investment info

Accepting
Min. investment
1 USD
Distributed in ICO
49,35%

Xeophin whitepaper

Xeophin team

Apply as an advisor

Travis Molloy Bsc

EXECUTIVE CHAIRMAN

Troy Neilson

CHIEF EXECUTIVE OFFICER & MANAGING DIRECTOR

Jason Yeates

CHIEF FINANCIAL OFFICER, SENIOR VICE PRESIDENT OF BUSINESS DEVELOPMENT & COLLABORATIONS

ICOs that might interest you

Filmgrid is a blockchain platform for commerce, streaming and financing of independent films and ...

Dec 16, 2018
Platform
4.3

Crypt-ON - a multiservice p2p platform to provide safe and secure transactions based on smart con...

Sep 14, 2018
Platform
3.9

The way of knowing the world, reinvented.

Dec 17, 2018
Platform
3.8

“Open Packaging Network” - an open ecosystem for stakeholders transactions.

Oct 1, 2018